Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Karen Prange currently holds 29,334 shares of NEVRO CORP (NVRO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Karen Prange has been a net seller of NVRO stock. They have purchased $100.0K and sold $1.1M worth of shares.
Karen Prange's most recent insider trade was on Jun 4, 2026, when they sold 10,667 shares at $0.00 per share.
Karen Prange serves as Executive at NEVRO CORP (NVRO). They have executed 59 insider transactions totaling $1.2M over their tenure at the company.
Karen Prange holds the position of Executive at NEVRO CORP, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 13 years and currently hold a stake valued at $0.
Karen Prange has shown a selling trading pattern, with $100.0K in total purchases and $1.1M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Karen Prange was on Jul 7, 2015, when they sold $308.3K worth of BSX shares. This transaction involved 17,456 shares at $17.66 per share.
Karen Prange currently owns 29,334 shares of NEVRO CORP (NVRO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Karen Prange's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Karen Prange has 59 Form 4 filings on record as an insider at NEVRO CORP.
Set alerts for Karen Prange and 40,000+ other insiders.